Categories AlphaGraphs, Cannabis, Earnings
Tilray Q2 loss widens despite revenue growth; results miss
Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked increase in revenues.
Revenues of the Canada-based company increased by 10% to $50.4 million in the June quarter but fell short of the forecast. The growth reflects strong performance by the cannabis adult-use and international-medical channels.
Meanwhile, net loss widened to $81.69 million or $0.66 per share in the second quarter from $36.3 million or $0.37 per share in the comparable period of 2019. Analysts were looking for a narrower loss for the latest quarter.
Tilray’s stock has fallen 74% in the past twelve months. The stock closed Monday’s regular session higher but dropped sharply during the extended session soon after the announcement.
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
